Valeritas (VLRX) Upgraded to Sell at ValuEngine
Valeritas (NASDAQ:VLRX) was upgraded by investment analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Friday.
Valeritas (NASDAQ VLRX) traded up $0.35 during midday trading on Friday, hitting $4.64. 29,746 shares of the company traded hands, compared to its average volume of 30,941. The company has a debt-to-equity ratio of 3.54, a current ratio of 3.88 and a quick ratio of 3.20. Valeritas has a 1 year low of $2.00 and a 1 year high of $40.96.
An institutional investor recently bought a new position in Valeritas stock. C WorldWide Group Holding A S purchased a new stake in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 233,952 shares of the company’s stock, valued at approximately $1,603,000. C WorldWide Group Holding A S owned approximately 3.42% of Valeritas at the end of the most recent quarter. 5.74% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: “Valeritas (VLRX) Upgraded to Sell at ValuEngine” was published by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/12/01/valeritas-vlrx-upgraded-to-sell-at-valuengine.html.
Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Valeritas Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.